Pan Zheng

Also affiliated with South China University of Technology

Immunology and MicrobiologyMedicineEngineering

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 26 papers. Top paper: “CD24-Siglec axis is an innate immune checkpoint against metaflammation and metabolic disorder”.

CD24-Siglec axis is an innate immune checkpoint against metaflammation and metabolic disorder

Cell Metabolism(2022)10.1016/j.cmet.2022.07.005

N/A

1.8DataRank · unranked

68 citations

Mingyue Liu, Jifeng Zhang, Nicholas K. Brown, Peng Zhang, Yan Zhang +11 more

Targeting HIF-1α abrogates PD-L1–mediated immune evasion in tumor microenvironment but promotes tolerance in normal tissues

Journal of Clinical Investigation(2022)10.1172/jci150846

N/A

0.748DataRank · unranked

145 citations

Yan Liu, Mingyue Liu, Xuexiang Du, Martin Devenport, Pan Zheng +3 more

CD24Fc ameliorates immune-related adverse events while preserving anti-tumor therapeutic effect

Signal Transduction and Targeted Therapy(2022)10.1038/s41392-022-01030-x

N/A

0.406DataRank · unranked

14 citations

Xu Wang, Xuexiang Du, Yan Zhang, Chunxia Ai, Siwen Hu‐Lieskovan +5 more

A novel aptamer-based small RNA delivery platform and its application to cancer therapy

Genes & Diseases(2022)10.1016/j.gendis.2022.05.004

N/A

0.373DataRank · unranked

11 citations

Peng Zhang, Christopher M. Bailey, Yin Wang, Wannaporn Ittiprasert, Martin Devenport +3 more

Safety and clinical activity of target-preserving anti-CTLA-4 antibody ONC-392 as monotherapy in NSCLC patients who progressed on PD(L)1-targeted immunotherapy.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.9024

N/A

0.312DataRank · unranked

7 citations

David P. Carbone, Meredith McKean, Rama Balaraman, Satish Shah, Edward Arrowsmith +11 more

CTLA-4 antibody-drug conjugate reveals autologous destruction of B-lymphocytes associated with regulatory T cell impairment

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.03.01.530608

N/A

0.165DataRank · unranked

2 citations

Xuexiang Du, Mingyue Liu, Xu Wang, Wei Wu, Chunxia Ai +4 more

CD24-p53 axis suppresses diethylnitrosamine-induced hepatocellular carcinogenesis by sustaining intrahepatic macrophages

UNC Libraries(2020)10.17615/t1g5-8s29

N/A

0.104DataRank · unranked

1 citations

Jing Liang, Ping Liu, Dongling Li, Pan Zheng, Lishan Su +8 more

533 An open label Phase IA/IB study for safety, pharmacokinetics (PK), and efficacy of ONC 392 as a single agent and in combination with Pembrolizumab in advanced solid tumors

Regular and Young Investigator Award Abstracts(2021)10.1136/jitc-2021-sitc2021.533

N/A

0DataRank · unranked

0 citations

Kun He, Yang Liu, Pan Zheng

Soluble CTLA-4 mutants ameliorate immune-related adverse events but preserve efficacy of CTLA-4– and PD-1–targeted immunotherapy

Science Translational Medicine(2023)10.1126/scitranslmed.abm5663

N/A

0DataRank · unranked

18 citations

Xu Wang, Xuexiang Du, Wei Wu, Yan Zhang, Peng Zhang +8 more

Genetic and pharmaceutical targeting of HIF1α allows combo-immunotherapy to boost graft vs. leukemia without exacerbation graft vs. host disease

Cell Reports Medicine(2023)10.1016/j.xcrm.2023.101236

N/A

0DataRank · unranked

5 citations

Yuanyi Wei, Jinsong Yan, Dan Huang, Peng Zhang, Chong Qi +9 more

CD24-Fc suppression of immune related adverse events in a therapeutic cancer vaccine model of murine neuroblastoma

Frontiers in Immunology(2023)10.3389/fimmu.2023.1176370

N/A

0DataRank · unranked

5 citations

Priya Srinivasan, Mousumi Basu, Talia Zimmerman, Samuel Li, Yin Wang +4 more

CTLA-4 antibody-drug conjugate reveals autologous destruction of B-lymphocytes associated with regulatory T cell impairment

eLife(2023)10.7554/elife.87281.3

N/A

0DataRank · unranked

1 citations

Xuexiang Du, Mingyue Liu, Xu Wang, Wei Wu, Chunxia Ai +4 more

Data from FOXP3 Up-regulates p21 Expression by Site-Specific Inhibition of Histone Deacetylase 2/Histone Deacetylase 4 Association to the Locus

(2023)10.1158/0008-5472.c.6499698.v1

N/A

0DataRank · unranked

0 citations

Lizhong Wang, Guoyun Chen, Hiroto Katoh, Chong Chen, Yang Liu +2 more

Data from Identification of a Tumor Suppressor Relay between the FOXP3 and the Hippo Pathways in Breast and Prostate Cancers

(2023)10.1158/0008-5472.c.6502835.v1

N/A

0DataRank · unranked

0 citations

Lizhong Wang, Hiroto Katoh, Runhua Liu, Pan Zheng, Yang Liu +1 more

Data from B7 Blockade Alters the Balance between Regulatory T Cells and Tumor-reactive T Cells for Immunotherapy of Cancer

(2023)10.1158/1078-0432.c.6517971

N/A

0DataRank · unranked

0 citations

Xincheng Zheng, Huiming Zhang, Yang Liu, Pan Zheng, Penghui Zhou

IL-27 Gene Therapy Ameliorates IPEX Syndrome Caused by Germline Mutation of Foxp3 Gene: A Major Role for Induction of IL-10

The Journal of Immunology(2024)10.4049/jimmunol.2400056

N/A

0DataRank · unranked

3 citations

Ali Jabbari, Cho-Hao Lin, Akkanapally Venu, Wendy L. Frankel, Sujit Basu +5 more

Siglec-H-/- Plasmacytoid Dendritic Cells Protect Against Acute Liver Injury by Suppressing IFN-γ/Th1 Response and Promoting IL-21+ CD4 T Cells

Cellular and Molecular Gastroenterology and Hepatology(2024)10.1016/j.jcmgh.2024.101367

N/A

0DataRank · unranked

6 citations

Jiapeng Wu, Masaya Funaki, Jair Flores, Xu Wang, Pan Zheng +3 more

CD24-Fc resolves inflammation and rescues CD8 T cells with polyfunctionality in humanized mice infected with HIV-1 under cART

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.12.16.628615

N/A

0DataRank · unranked

0 citations

Jianping Ma, Haisheng Yu, Ourania Tsahouridis, Yaoxian Lou, Xiuting He +7 more

Mechanism- and Immune Landscape-Based Ranking of Therapeutic Responsiveness of 22 Major Human Cancers to Next Generation Anti-CTLA-4 Antibodies

Cancers(2020)10.3390/cancers12020284

N/A

0DataRank · unranked

14 citations

Xinxin Xiong, Christian Rolfo, Xuexiang Du, Yan Zhang, Han Yang +6 more

pH-dependent dissociation from CTLA-4 in early endosomes improves both safety and antitumor activity of anti-CTLA-4 antibodies

Proceedings of the National Academy of Sciences(2025)10.1073/pnas.2422731122

N/A

0DataRank · unranked

5 citations

Jin Li, Kepeng Yan, Haoyue Zhou, Song Mei, Benyu Wang +11 more

Liposomal formulation of HIF-1α inhibitor echinomycin eliminates established metastases of triple-negative breast cancer

Nanomedicine Nanotechnology Biology and Medicine(2020)10.1016/j.nano.2020.102278

N/A

0DataRank · unranked

45 citations

Yan Liu, Gong Peng, Huixia Zhang, Miao He, Duxin Sun +4 more

FOXP3 Is an X-Linked Breast Cancer Suppressor Gene and an Important Repressor of the HER-2/ErbB2 Oncogene

UNC Libraries(2020)10.17615/ky7v-r453

N/A

0DataRank · unranked

1 citations

Cun Yu Wang, Jin-Qing Liu, Tianyu Yang, Xingluo Liu, Rulong Shen +16 more

First-in-human phase I/II clinical trial of ONC-392: Preserving CTLA-4 immune tolerance checkpoint for safer and more effective cancer immunotherapy.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.tps3159

N/A

0DataRank · unranked

1 citations

Søren M. Bentzen, Martin Devenport, Yang Liu, Pan Zheng, Christian Rolfo

Intracellular CD24 disrupts the ARF–NPM interaction and enables mutational and viral oncogene-mediated p53 inactivation

UNC Libraries(2020)10.17615/hamj-mq75

N/A

0DataRank · unranked

0 citations

Penghui Zhou, Guo‐Yun Chen, Peiying Ye, Yanping Zhang, Taijiao Jiang +12 more

Dual Targeting Oncoproteins MYC and HIF1α Regresses Tumor Growth of Lung Cancer and Lymphoma

Cancers(2021)10.3390/cancers13040694

N/A

0DataRank · unranked

15 citations

Yan Liu, Yan Liu, Yin Wang, Christopher M. Bailey, Pan Zheng +2 more

Treatment with Soluble CD24 Attenuates COVID-19-Associated Systemic Immunopathology

medRxiv(2021)10.1101/2021.08.18.21262258

N/A

0DataRank · unranked

3 citations

Carter Allen, Anna E. Vilgelm, Brian Riesenberg, Kevin P. Weller, Kelsi Reynolds +25 more